Memphis Pharmaceuticals (MPCI.CA) Reports 6 Months Results
16/02/2022
16/02/2022
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 9,584,547
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 18,815,819
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 9,584,547
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 18,815,819
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
